SCHEMBL15950982

SCHEMBL15950982

O=C1c2ccccc2C(=O)c2c1oc1cc(O)cc(O)c21

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ APP P05067 3/20 0.61
▸ TRPC5 Q9UL62 3/20 0.57
▸ MEN1 O00255 7/20 0.56
▸ KMT2A Q03164 7/20 0.56
▸ HSP90AA1 P07900 1/20 0.56
▸ CYP3A4 P08684 5/20 0.54
▸ MAPT P10636 5/20 0.54
▸ CYP2C9 P11712 5/20 0.54
▸ ABCB1 P08183 5/20 0.54
▸ CYP2D6 P10635 4/20 0.54
▸ CYP2C19 P33261 4/20 0.54
▸ XDH P47989 4/20 0.54
▸ FTO Q9C0B1 4/20 0.54
▸ TP53 P04637 4/20 0.54
▸ CA12 O43570 3/20 0.54
▸ CYP1A1 P04798 3/20 0.54
▸ CYP1A2 P05177 3/20 0.54
▸ PPARG P37231 3/20 0.54
▸ CA7 P43166 3/20 0.54
▸ CYP1B1 Q16678 3/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1520210 0.83 NTRK1 (0.53) APPMEN1KMT2ACYP3A4MAPT
SCHEMBL28621891 0.83 APP (0.49) APPTRPC5MEN1KMT2AHSP90AA1
SCHEMBL7572043 0.81 NTRK1 (0.51) APPTRPC5MEN1KMT2ACYP3A4
SCHEMBL3270938 0.77 TERT (0.52) ADORA3HDAC6HDAC8
SCHEMBL2495022 0.77 TERT (0.54) MEN1KMT2ACYP3A4MAPTCYP2C9
Datiscetin SCHEMBL43916 0.76 APP (1.00) APPTRPC5MEN1KMT2AHSP90AA1
Datiscetin SCHEMBL29737517 0.76 APP (1.00) APPTRPC5MEN1KMT2AHSP90AA1
Datiscetin SCHEMBL30822630 0.76 APP (1.00) APPTRPC5MEN1KMT2AHSP90AA1
SCHEMBL15942094 0.75 TOP1 (0.55) ADORA3BCHEACHE
SCHEMBL15951016 0.75 GAA (0.47) APPTRPC5MEN1KMT2AHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9956226-B2 Methods and compounds for the inhibition of cellular proliferation PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2018-05-01 — — US disclosed
US-9956226-B2 Methods and compounds for the inhibition of cellular proliferation PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2018-05-01 — — US disclosed
US-9956226-B2 Methods and compounds for the inhibition of cellular proliferation PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2018-05-01 — — US disclosed
US-20150374707-A1 Methods and Compounds for the Inhibition of Cellular Proliferation PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2015-12-31 — — US disclosed
US-20150374707-A1 Methods and Compounds for the Inhibition of Cellular Proliferation PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2015-12-31 — — US disclosed
US-20150374707-A1 Methods and Compounds for the Inhibition of Cellular Proliferation PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2015-12-31 — — US disclosed
WO-2014124412-A2 METHODS AND COMPOUNDS FOR THE INHIBITION OF CELLULAR PROLIFERATION PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2014-08-14 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150374707-A1 Methods and Compounds for the Inhibition of Cellular Proliferation MKI67, PCNA, DDX21 APP 4608/4885TRPC5 4467/4885MEN1 2600/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback